Congress passes, President signs continuing resolution for FY 2013

Funding for HIV through PEPFAR "took a hit while the Global Fund to Fight AIDS, Tuberculosis and Malaria got a boost last week when the House and Senate passed a Continuing Resolution bill to avoid a government shutdown and continue funding the government through Oct. 1, the end of fiscal year 2013," the Center for Global Health Policy's "Science Speaks" blog reports (Aziz, 3/26). Politico 44 notes that President Obama signed the continuing budget resolution into law on Tuesday (Slack, 3/26). "Under the resolution, PEPFAR is slated to receive $4.067 billion, a $176 million ... cut from the FY 2012 level of $4.243 billion," "Science Speaks" writes, adding, "An additional five percent cut from the automatic across-the-board budget cuts known as sequestration, means PEPFAR's total is $3.863 billion -- $380 million below FY 2012 spending and the lowest funding level since FY 2007." The blog continues, "In contrast, the Global Fund's new funding under the resolution is $1.648 billion, up 27 percent, or $348 million from the $1.3 billion received in FY 2012. With the five percent cut from sequestration, the Global Fund will still get more than last year: $1.566 billion for FY 2013" (3/26). "The support was announced in a press release by the Global Fund," Intellectual Property Watch notes (Burke, 3/25). Additional information about the FY13 Continuing Resolution is available from the Kaiser Family Foundation's "Policy Tracker" (3/21).

http://www.kaiserhealthnews.orgThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Brazilian researchers identify possible biomarkers associated with recurrence of vivax malaria